503 related articles for article (PubMed ID: 15084693)
21. Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia.
Fruchart C; Lenormand B; Bastard C; Boulet D; Lesesve JF; Callat MP; Stamatoullas A; Monconduit M; Tilly H
Am J Hematol; 1996 Nov; 53(3):175-80. PubMed ID: 8895688
[TBL] [Abstract][Full Text] [Related]
22. Gene rearrangements in bone marrow cells of patients with acute myelogenous leukemia.
Schmetzer HM; Braun S; Wiesner D; Duell T; Gerhartz HH; Mittermueller J
Acta Haematol; 2000; 103(3):125-34. PubMed ID: 10940650
[TBL] [Abstract][Full Text] [Related]
23. Dyshematopoiesis in de novo acute myeloid leukemia: cell biological features and prognostic significance.
Meckenstock G; Aul C; Hildebrandt B; Heyll A; Germing U; Wehmeier A; Giagounidis A; Suedhoff T; Burk M; Soehngen D; Schneider W
Leuk Lymphoma; 1998 May; 29(5-6):523-31. PubMed ID: 9643566
[TBL] [Abstract][Full Text] [Related]
24. Frequency of prolonged remission duration after high-dose cytarabine intensification in acute myeloid leukemia varies by cytogenetic subtype.
Bloomfield CD; Lawrence D; Byrd JC; Carroll A; Pettenati MJ; Tantravahi R; Patil SR; Davey FR; Berg DT; Schiffer CA; Arthur DC; Mayer RJ
Cancer Res; 1998 Sep; 58(18):4173-9. PubMed ID: 9751631
[TBL] [Abstract][Full Text] [Related]
25. Survival differences and associated molecular signatures of DNMT3A-mutant acute myeloid leukemia patients.
Lauber C; Correia N; Trumpp A; Rieger MA; Dolnik A; Bullinger L; Roeder I; Seifert M
Sci Rep; 2020 Jul; 10(1):12761. PubMed ID: 32728112
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic significance of cytogenetic changes in patients with acute myeloid leukemia (AML). (Analysis of results in 105 patients treated at the Hemato-oncology Clinic of the University Hospital in Olomouc from 1997 to 2000].
Jarosová M; Indrák K; Holzerová M; Hubácek J; Faber E; Papajík T; Raida L; Szotkowski T; Knotková R; Hlusí T; Jedlicková K; Pikalová Z; Sulovská I
Vnitr Lek; 2001 Sep; 47 Suppl 1():8-14. PubMed ID: 11693065
[TBL] [Abstract][Full Text] [Related]
27. Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy.
Kern W; Haferlach T; Schnittger S; Ludwig WD; Hiddemann W; Schoch C
Leukemia; 2002 Oct; 16(10):2084-91. PubMed ID: 12357361
[TBL] [Abstract][Full Text] [Related]
28. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.
Schnittger S; Schoch C; Dugas M; Kern W; Staib P; Wuchter C; Löffler H; Sauerland CM; Serve H; Büchner T; Haferlach T; Hiddemann W
Blood; 2002 Jul; 100(1):59-66. PubMed ID: 12070009
[TBL] [Abstract][Full Text] [Related]
29. Prognosis of acute myeloid leukemia patients up to 60 years of age exhibiting trisomy 8 within a non-complex karyotype: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
Schaich M; Schlenk RF; Al-Ali HK; Döhner H; Ganser A; Heil G; Illmer T; Krahl R; Krauter J; Sauerland C; Büchner T; Ehninger G
Haematologica; 2007 Jun; 92(6):763-70. PubMed ID: 17550848
[TBL] [Abstract][Full Text] [Related]
30. Chromosome aberrations, gene mutations and expression changes, and prognosis in adult acute myeloid leukemia.
Mrózek K; Bloomfield CD
Hematology Am Soc Hematol Educ Program; 2006; ():169-77. PubMed ID: 17124057
[TBL] [Abstract][Full Text] [Related]
31. [Cytogenetic risk categories in acute myeloid leukemia: a comparison between MRC (Medical Research Council) and SWOG (Southwest Oncology Group) models)].
Martín Ramos ML; López Pastor M; de la Serna Torroba J; Ayala R; García Alonso L; Barreiro Miranda E
Med Clin (Barc); 2003 Jun; 121(4):121-5. PubMed ID: 12867014
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of acute myeloid leukemia samples from adult patients with AML-M1 and -M2 through boutique microarrays, real-time PCR and droplet digital PCR.
Handschuh L; Kaźmierczak M; Milewski MC; Góralski M; Łuczak M; Wojtaszewska M; Uszczyńska-Ratajczak B; Lewandowski K; Komarnicki M; Figlerowicz M
Int J Oncol; 2018 Mar; 52(3):656-678. PubMed ID: 29286103
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of cytogenetic findings in adults with acute myeloid leukemia.
Mrózek K; Heinonen K; Bloomfield CD
Int J Hematol; 2000 Oct; 72(3):261-71. PubMed ID: 11185980
[TBL] [Abstract][Full Text] [Related]
34. Acute leukemia: subtype discovery and prediction of outcome by gene expression profiling.
Downing JR
Verh Dtsch Ges Pathol; 2003; 87():66-71. PubMed ID: 16888896
[TBL] [Abstract][Full Text] [Related]
35. Association of specific cytogenetic aberrations with mdr1 gene expression in adult myeloid leukemia and its implication in treatment outcome.
Schaich M; Harbich-Brutscher E; Pascheberg U; Mohr B; Soucek S; Ehninger G; Illmer T
Haematologica; 2002 May; 87(5):455-64. PubMed ID: 12010657
[TBL] [Abstract][Full Text] [Related]
36. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
[TBL] [Abstract][Full Text] [Related]
37. Validation of risk stratification models in acute myeloid leukemia using sequencing-based molecular profiling.
Wang M; Lindberg J; Klevebring D; Nilsson C; Mer AS; Rantalainen M; Lehmann S; Grönberg H
Leukemia; 2017 Oct; 31(10):2029-2036. PubMed ID: 28167833
[TBL] [Abstract][Full Text] [Related]
38. Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures.
Serrano E; Lasa A; Perea G; Carnicer MJ; Brunet S; Aventín A; Sierra J; Nomdedéu JF
Acta Haematol; 2006; 116(2):77-89. PubMed ID: 16914901
[TBL] [Abstract][Full Text] [Related]
39. New insights into the biology of acute myeloid leukemia and their impact on treatment.
Hiddemann W; Haferlach T; Schoch C; Behre G; Kohlmann A; Kern W; Feuring-Buske M; Bohlander S
Verh Dtsch Ges Pathol; 2003; 87():72-8. PubMed ID: 16888897
[TBL] [Abstract][Full Text] [Related]
40. Cytogenetics in acute myeloid leukemia.
Schoch C; Haferlach T
Curr Oncol Rep; 2002 Sep; 4(5):390-7. PubMed ID: 12162912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
